Blog
RSS FeedPosted by Michael Wonder on 02 Apr 2020
Seqirus announces positive CHMP Opinion for its adjuvanted quadrivalent influenza vaccine
31 March 2020 - Seqirus today announced that its adjuvanted quadrivalent influenza vaccine - launching as Fluad Tetra - has received ...
Posted by Michael Wonder on 24 Mar 2020
Eleven states now letting uninsured sign up for Obamacare
23 March 2020 - More coronavirus care will be covered in many states. Federal officials are considering similar action for the ...
Posted by Michael Wonder on 18 Mar 2020
COVID-19: an update from Dr. Brian O’Rourke, CADTH President and CEO
18 March 2020 - As our country deals with the COVID-19 situation, CADTH has implemented several initiatives to mitigate the ...
Posted by Michael Wonder on 14 Mar 2020
Insulin costs may be capped in a Medicare program
11 March 2020 - If drug companies and insurers agree to participate, the Trump administration proposes limiting insulin costs to $35 ...
Posted by Michael Wonder on 18 Feb 2020
Population-based payments may help ensure access to life-saving antibiotics for Medicare beneficiaries
18 February 2020 - In 2019, the Centers for Disease Control and Prevention (CDC) released an updated report on Antibiotic Resistance ...
Posted by Michael Wonder on 13 Feb 2020
How protected classes in Medicare Part D influence U.S. drug sales, utilisation, and price
13 February 2020 - When the Medicare Part D prescription drug benefit was implemented in 2006, six drug classes were designated ...
Posted by Michael Wonder on 06 Feb 2020
Proposed changes to Medicare Advantage and Part D will provide better coverage, more access and improved transparency for Medicare beneficiaries
5 February 2020 - Proposed rule and Advance Notice continue to strengthen the popular private Medicare health and drug plans. ...
Posted by Michael Wonder on 21 Jan 2020
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma
21 January 2020 - Novel combination regimen includes first-in-class antibody-drug conjugate that specifically targets CD79b. ...
Posted by Michael Wonder on 09 Jan 2020
Can we please stop fighting about ‘Medicare for all’?
8 January 2020 - One policy proposal has defined this Democratic race. It’s time to move on. ...
Posted by Michael Wonder on 19 Dec 2019
Who pays in Medicare Part D? Giving plans more skin in the game.
19 December 2019 - As U.S. policy makers debate proposals for reforming the prescription-drug marketplace, they should recognise the need to ...
Posted by Michael Wonder on 09 Dec 2019
Medicare costs for seniors lowered in Senate drug price bill
7 December 2019 - Seniors would pay a smaller portion of their drugs’ cost and be shielded from huge one-time ...
Posted by Michael Wonder on 06 Dec 2019
Pelosi sets Medicare showdown on drug costs and new benefits
6 December 2019 - The House will hold a showdown vote next week on Speaker Nancy Pelosi’s bill empowering Medicare ...
Posted by Michael Wonder on 28 Nov 2019
Medicare bill ‘puts every Australian at risk’
28 November 2019 - A new Medicare anti-fraud bill would put the privacy of every Australian at risk and create ...
Posted by Michael Wonder on 21 Nov 2019
Pricing tactics slow uptake of generic drugs by Medicare plans
21 November 2019 - Study finds new copycat medicines take years to win coverage. ...
Posted by Michael Wonder on 19 Nov 2019
Elizabeth Warren says ‘Medicare for All’ rollout process will take 3 years
16 November 2019 — Elizabeth Warren announced Friday that she would expand public health insurance during her first 100 days ...